Clinical Trial Update: Study of (Telintra®) in Non-Del(5q) Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 study of Telintra in non-Del(5q) myelodysplastic syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Telintra

Snippet

Sponsor: Telik | Conditions: Myelodysplastic Syndrome (MDS) | Phase 2 | Status: TERMINATED